ID
32907
Beschrijving
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form asks for concomitant medications of the subject. It should be filled out at first visit, and re-checked at each subsequent visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00241644
Trefwoorden
Versies (3)
- 01-11-18 01-11-18 -
- 17-11-18 17-11-18 -
- 19-11-18 19-11-18 - Sarah Riepenhausen
Houder van rechten
GlaxoSmithKline
Geüploaded op
19 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Concomitant Medication
- StudyEvent: ODM
Beschrijving
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Beschrijving
Medication Data
Alias
- UMLS CUI-1
- C2347852
Beschrijving
Trade/Name of Medication
Datatype
text
Alias
- UMLS CUI [1]
- C2360065
Beschrijving
Medical Indication
Datatype
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Beschrijving
Prophylactic Medication
Datatype
boolean
Alias
- UMLS CUI [1]
- C0420172
Beschrijving
Total daily dose
Datatype
text
Alias
- UMLS CUI [1]
- C2348070
Beschrijving
Medication Route
Datatype
text
Alias
- UMLS CUI [1]
- C0013153
Beschrijving
Start Date of Medication
Datatype
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Beschrijving
End Date of Medication
Datatype
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Beschrijving
Continuing Medication
Datatype
boolean
Alias
- UMLS CUI [1]
- C2826666
Beschrijving
Only to be filled out by GSK staff members
Datatype
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0008961
Similar models
Concomitant Medication
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,2])